These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28845699)

  • 1. Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation
    Zainuddin R; Zaheer Z; Sangshetti JN; Momin M
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2076-2084. PubMed ID: 28845699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
    Rao MRP; Chaudhari J; Trotta F; Caldera F
    AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Bioavailability of Non-nucleoside Reverse Transciptase Inhibitor Using Nanosponges.
    Rao MRP; Shirsath C
    AAPS PharmSciTech; 2017 Jul; 18(5):1728-1738. PubMed ID: 27757921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability.
    Dora CP; Trotta F; Kushwah V; Devasari N; Singh C; Suresh S; Jain S
    Carbohydr Polym; 2016 Feb; 137():339-349. PubMed ID: 26686138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X; Zhang T; Lan Y; Wu B; Shi Z
    AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
    Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
    Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
    Sangwai M; Vavia P
    Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
    Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution.
    Rao MR; Bhingole RC
    Drug Dev Ind Pharm; 2015; 41(12):2029-36. PubMed ID: 26006328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.